Cassava Science hopefully close above 70Great price action we have been waiting for, but seems not strong enough.
SAVA trade ideas
Trade update on SAVA
Entered at $47 and closed the trade at $65. I think it finished the Wave 1 of the reversal and now will be spending next few days in correction. This correction can take it back to $49-$51 range where we will make the decision again to go long.
It just follows the planI love this stock, so far has been following the plan we have been shared all the time.
SAVA Breakout IdeaSAVA breaking out as MACD line crosses signal line, RSI bounces off of 30, and approaching 200 day SMA.
SAVA due to run.Not a financial advisor.
I entered here last week for a swing play. I may change depending on how this unfolds. Clearly oversold.
SAVA is looking to get above that 200MA near the $54 dollar mark. I see a fib level for $68.55. Which I strongly believe we could see in the short term here as we gain momentum.
RSI is near the oversold mark, currently sitting at 37.44
Momentum is looking to go from negative to positive.
MACD is now crossing bullish
Keep in mind SAVA has been over $100 twice on major runs. If we start to gain momentum and start getting over the 200 (first) 100 MA (second, light blue) theres no doubt in my mind that $100 can be here in the mid term.
Stocks go up and down, rare cases they halt and go straight up. However even after a major increase things need to stabilize. We just saw a major decrease, and now it appears that we have found buyers at these levels. Should be climbing back up towards $100 in the short to mid term here.
$SAVA Butterfly Long on Daily Inside bar break high Clean butterfly, buyers off 1.272 ext led to an inside bar at trigger level of this butterfly, let's see how it does. Very volatile// $SAVA
Time to reverseLooks like we are close to the bottom and the sell off might be fading away. Will be looking for signs of buying in this ticker.
Caution: Need to be watchful of the news since the last one was pretty bad for the company.
SAVA more of a technical play than speculative?NASDAQ:SAVA
It seems to be more of a technical play to me than just news based. What do you all think?
$SAVA Gappy Short attack or legitimate fraud ?
We've seen these claims before go both ways , High Risk High Reward here IMO . Entered credit spread 45/40P for 10/15 given the buyers stepped in at the 200MA very strongly. Wouldn't be surprised if this was trading back in the 100s or 20s by next week :) 99% of gaps get filled, just a matter of when ...
$SAVA Gap & Go Bat pattern/ $LOV & $PRVA Clean looks as well I am looking for a gap down or soft open on $SAVA 77-71$ Price reversal zone i highlighted. It could easily go higher from here as well, if anyone is long. I am looking for a shake of weak hands type move, that is all. Tp 1 level highlighted i personally take 1/2 & stop loss is moved to entry. This is Still in Tp 2 of butterfly (larger) I will share it below, Koyfin Highlights will be attached for DD, Thanks for checking these out!
Calls of interest at sub 77$ level
August 27th 100's (ST)
September 17 100's
August 27th 100's (ST)
SAVA "Scene of the Crime" trade. BTDWow, my pendulum picked this one yesterday and I see it's down 25% this morning ($81.00) on an accusation regarding a trial. My dowsing is saying this is a "Scene of the Crime" opportunity, which just means it goes back to where it was before the news hit. I hope so!
$SAVA - H/SThis looks like a head and shoulders pattern and an imminent collision with the 200 day EMA.
NASDAQ:SAVA
Stocks - SAVA Short PT 36 Sept 8-27Idea for Cassava Sciences (SAVA):
- Decoded:
PVVol:
- H&S pattern, Distribution UTAD with Exhaustion gap (Price).
- High Volume sell (Volume).
- > 5x ATR (Vol).
- 4.236 Fib.
- ML Diamond.
PT: 36
Time: By Sept 8, but add 0.3 bars margin (Sept 27)
SL: 2.4N~ 128.38
GLHF
- DPT
$SAVA | New ATH due to new catalysts?The CEO Remi Barber lately teased a possible partnership which will be announced within the next weeks. This could have a huge impact on the SP of Cassava Sciences. As a consequence we might see a new ATH soon!
$SAVA | Perfect dipAfter the announcement of positive data, the stock price plunged over 50% within 2 days. It's simply called "sell the news". I locked some profits around 130$ and now started to buy the dip. Next week we will most likely see a rebounce.
*That is no financial advice - please do your own due diligence before investing
Picking this idea back againi mentioned about shorting this again once its close to 115 and looks like we are almost there. We might see a final leg up but i already see RSI drowing showing less buyer interest. Might take a short tomorrow if i see further weakness and wedge being taken out.
Update to ShortsI covered my Sava shorts as it hit my SL and now looking to do it again at around $115 if i see the weakness.
Can SAVA get back to $100 in the short term? $SAVA (Cassava Sciences) saw an insane rally in 2021 from $7 to $145 on the hopes that its groundbreaking Alzheimer's treatment will yield promising results never before seen in the history of the disease. Currently there are no Alzheimer's modifying therapies on the market and if the data surrounding Cassava's main drug, simufilam, is accurate then it could be the first of its kind.
SAVA saw a sell-the-news event when it announced its promising results, suffering a 23% drop on July 29. Soon thereafter a Stat News article was released criticizing Cassava's results, citing a group of independent researchers. The stock dropped a total of 55% from highs.
Is this a buying opportunity? Obviously we are largely delving in uncharted territory and financial analysts/traders won't be able to infer whether the science is reliable or not. However, traders know how market cycles largely work. There is often a second wave of optimism after negative news coverage (whether a short report or a hit piece), driven by those who are willing to speculate.
SAVA is showing a bullish harami on the 1D and it has dropped to the Fibonacci golden pocket level, also at the 100 MA where it has routinely found support. This could be a buying opportunity for those who are in the market for a bit of risk. As long as #SAVA is above the 100 MA, I'm willing to hold it in the mid term and will ride the next wave of positive financial/medical news.
Entry: $79
SL: soft SL with manual monitoring if it breaches the 100 MA
TP: $88, $94, $100
SAVA Stuck At 382It's interesting to see what happens after plotting out fib lines sometimes. SAVA , for instance...using the earlier lows and the recent high as anchors we can see that the 382 fib line has been a very clear area of both support and resistance almost to the exact mark. Sure 236 played this role before the Alzheimer's data but now SAVA has reset back to some familiar territory and, so far, is mimicking its trend before the big breakout, which is 382 fib resistance being an issue. Multiple times in the last few days, this area was tested and SAVA was rejected (including 8/3). BUT with the market seemingly building optimism, it could once again be an important area on the chart to be aware of.
"The biotech industry is well known for volatility. When you’re talking about developing life-changing treatments, there’s a lot to account for. The phase trial process brings the potential for big progress but can also put the brakes on otherwise strong rallies in the market. We recently saw this with companies like Cassava Sciences (NASDAQ: SAVA) and Annovis Bio (NYSE: ANVS ), which were also former penny stocks. Both companies developing Alzheimer’s treatments revealed data that didn’t impress the market at all. In response, shares of both stocks plummeted."
Quote Source & Read More: Hot Biotech Stocks To Watch After Sanofi’s Acquisition Of Translate Bio
$SAVA is gonna fall todayPupm&Dump trading strategy idea.
$SAVA is rising too much today.
The demand for shares of the company looks lower than the supply.
This and other conditions can cause a fall in the share price today.
So I opened a short position from $76,54;
stop-loss — $77,30;
take-profit — $75,02.
Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision.
Always do your own analysis before making deals. When you use any materials, do not rely on blind trust.
You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy.
If you like my content, you can subscribe to the news and receive my fresh ideas.
Thanks for being with me!
Further downsideWell the last one went according to the plan and looks like we have a much larger retrace than expected. Expect it to further bleed and stay in correction mode for sometime.
